David Matly
CIK: 0002062665
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INBX
Inhibrx Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
About Matly David
Matly David (SEC CIK 0002062665) files insider reports with the SEC as President of Inhibrx Biosciences, Inc. (INBX).
Signal8 holds 3 ownership filings by Matly David (1 Form 3, 2 Form 4), filed between Apr 2, 2025 and Apr 27, 2026. Those filings report 2 transactions, from Apr 1, 2025 to Apr 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Matly David's filings is in LA JOLLA, CA.
Recent filings by Matly David
Other insiders filing for Inhibrx Biosciences, Inc. (INBX)
- Lappe Mark, Chief Executive Officer
- Kayyem Jon Faiz, Director
- FORSYTH DOUGLAS, Director
- Vuori Kristiina MD, Director
- MANHARD KIMBERLY, Director
- VIKING GLOBAL INVESTORS LP, 10% Owner